Clinical Trial Update: Assess Diversity of Gut Microbiome in Met NSCLC in Correlation to Tx & Adverse Effects

View source ↗

Summary

This clinical trial in metastatic non-small cell lung cancer is evaluating gut microbiome diversity and its correlation with cancer treatment outcomes and adver…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: University of California, Irvine | Conditions: Non Small Cell Lung Cancer | Status: RECRUITING